Logo of clinexpimmunolLink to Publisher's site
Clin Exp Immunol. 1997 Nov; 110(2): 155–157.
PMCID: PMC2265494

The ins and outs of glomerular crescent formation

Full Text

The Full Text of this article is available as a PDF (284K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Volhard F, Fahr T. Die. Brightsche Nierenkrankheit. Berlin: Springer; 1914.
2. Whitworth JA, Morel-Maroger L, Mignon F, et al. The significance of extracapillary proliferation. Clinicopathological review of 60 patients. Nephron. 1976;16:1–19. [PubMed]
3. Lan HY, Nikolic-Paterson DJ, Mu W, et al. Local macrophage proliferation in the pathogenesis of glomerular crescent formation in rat anti-GBM glomerulonephritis. Clin Exp Immunol. 1997;110:233–40. [PMC free article] [PubMed]
4. Tomosugi NI, Cashman SJ, Hay H, et al. Modulation of antibody-mediated glomerular injury in vivo by bacterial lipopolysaccharide, tumour necrosis factor, and IL-1. J Immunol. 1989;142:3083–90. [PubMed]
5. Rees AJ, Lockwood CM, Peters DK. Enhanced allergic tissue injury in Goodpasture's syndrome by intercurrent bacterial infection. Br Med J. 1977;2:723–36. [PMC free article] [PubMed]
6. Morel-Maroger Striker L, Killen PD, Chi E, et al. The composition of glomerulosclerosis. I. Studies in focal sclerosis, crescentic glomerulonephritis, and membranoproliferative glomerulonephritis. Lab Invest. 1984;51:181–92. [PubMed]
7. Lan HY, Nikolic-Paterson DJ, Atkins RC. Involvement of activated periglomerular leukocytes in the rupture of Bowman's capsule and glomerular crescent progression in experimental glomerulonephritis. Lab Invest. 1992;67:743–51. [PubMed]
8. Tipping PG, Thomson NM, Holdsworth SR. A comparison of fibrinolytic and defibrinating agents in established experimental glomerulonephritis. Br J Exp Pathol. 1986;67:481–91. [PMC free article] [PubMed]
9. Mathieson PW, Thiru S, Peters DK, et al. Effects of Ancrod and rTPA on fibrin accumulation, glomerular inflammation and renal function in nephrotoxic nephritis. Int J Exp Pathol. 1991;72:679–93. [PMC free article] [PubMed]
10. Border WA. Anticoagulants are of little value in the treatment of renal disease. Am J Kidney Dis. 1984;3:308–12. [PubMed]
11. Kincaid-Smith P. Anticoagulants are of value in the treatment of renal disease. Am J Kidney Dis. 1984;3:299–307. [PubMed]
12. Tipping PG, Lowe MG, Holdsworth SR. Glomerular macrophages express augmented procoagulant activity in experimental fibrin-related glomerulonephritis in rabbits. J Clin Invest. 1988;82:1253–9. [PMC free article] [PubMed]
13. Sady SP, Goyal M, Thomas PE, et al. Fibronectin mRNA in the developing glomerular crescent in rabbit antiglomerular basement membrane disease. J Am Soc Nephrol. 1995;5:2087–90. [PubMed]
14. Chadban SJ, Tesch GH, Lan HY, et al. Effect of interleukin-10 treatment on crescentic glomerulonephritis in rats. Kidney Int. 1997;51:1809–17. [PubMed]
15. Boyce NW, Tipping PG, Holdsworth SR. Glomerular macrophages produce reactive oxygen species in experimental glomerulonephritis. Kidney Int. 1989;35:778–82. [PubMed]
16. Lloyd CM, Minto AW, Dorf ME, et al. RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J Exp Med. 1997;185:1371–80. [PMC free article] [PubMed]
17. Lan HY, Bacher M, Yang N, et al. The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. J Exp Med. 1997;185:1455–65. [PMC free article] [PubMed]
18. Waddington S, Cook HT, Reaveley D, et al. L-arginine depletion inhibits glomerular nitric oxide synthesis and exacerbates rat nephrotoxic nephritis. Kidney Int. 1996;49:1090–6. [PubMed]
19. Kitching AR, Holdsworth SR, Ploplis VA, et al. Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J Exp Med. 1997;185:963–8. [PMC free article] [PubMed]
20. Shimuzu A, Masuda Y, Kitamura H, et al. Apoptosis in progressive crescentic glomerulonephritis. Lab Invest. 1996;74:941–51. [PubMed]
21. Ren K, Brentjens J, Chen Y, et al. Glomerular macrophage proliferation in experimental immune complex nephritis. Clin Immunol Immunopathol. 1991;60:384–98. [PubMed]
22. Goto M, Matsuno K, Yamaguchi Y, et al. Proliferation kinetics of macrophage subpopulations in a rat experimental pancreatitis model. Arch Histol Cytol. 1993;56:75–82. [PubMed]
23. Burns AP, Fisher M, Li P, et al. Molecular analysis of HLA class II genes in Goodpasture's disease. Q J Med. 1995;88:93–100. [PubMed]
24. Kinjoh K, Kyogoku M, Good RA. Genetic selection for crescent formation yields mouse strain with rapidly progressive glomerulonephritis and small vessel vasculitis. Proc Natl Acad Sci USA. 1993;90:3413–7. [PMC free article] [PubMed]
25. Huang X-R, Tipping PG, Shuo L, et al. Thl responsiveness to nephrogenic antigens determines susceptibility to crescentic glomerulonephritis in mice. Kidney Int. 1997;51:94–103. [PubMed]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • PubMed
    PubMed citations for these articles

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...